The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

Jardim, Denis L., Goodman, Aaron, de Melo Gagliato, Debora, Kurzrock, Razelle·2021·Cancer Cell
DOI 10.1016/j.ccell.2020.10.001

Cited by (1,000)

Items 901–1,000 of 1,000

  1. A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma
    Xiaofeng Sun, Hao Song, Xiaoran Sun, Chunhua Liao, Guoqiang Wang, Yu Xu, Leo Li, Yusheng Han, C. Xu, Wenxian Wang et al. · 2024 · Cancer Investigation
  2. Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden
    Ivan P. Gorlov, Olga Y. Gorlova, Spyridon Tsavachidis, Christopher Ian Amos · 2024 · Scientific Reports
  3. Efficacy and Safety of Programmed Death 1/Programmed Death-Ligand 1 Plus Cytotoxic T-Lymphocyte–Associated Antigen 4 Inhibitors for Advanced or Metastatic Non–Small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials
    Wei Ren, Yingying Fang, Yujing He, Yifeng Ren, Minfang Wang, Anyi Xu, Jiale Ruan, Qinghua Tao · 2024 · Therapeutic Drug Monitoring
  4. Review of immunotherapy in non-small cell lung cancer: mechanisms, clinical applications, and future prospects
    Palwasha Habib · 2024 · Asia-Pacific Journal of Oncology
  5. Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)
    Young Kwang Chae, Megan K. D. Othus, Sandip Pravin Patel, David E. Gerber, Tawee Tanvetyanon, Hye Sung Kim, Liam Il‐Young Chung, Christine M. McLeod, Gabby Lopez, Helen X. Chen et al. · 2024 · Therapeutic Advances in Medical Oncology
  6. DPH2 is a biomarker associated with cell death, immunity and prognosis based on pan-cancer analysis
    Maolin Xiao, Shuai Su, Xiangbiao He, Liangdong Song, Delin Wang · 2025 · Discover Oncology
  7. Pan-Cancer Analysis of ANO6 and Experimental Validation in Metastatic Melanoma
    Yao An, Haoran Dong, Meishan Yan, Caixu Liu, Danfeng Hu, Qi Liu, Jingqiu Zhang, Xu Han, Zimeng Li, Minghui Xu et al. · 2025 · Biochemical Genetics
  8. An innovative glutamine metabolism-related gene signature for predicting prognosis and immune landscape in cervical cancer
    Hai-Ya Fang, Limei Ji, Cui-Hua Hong · 2025 · Discover Oncology
  9. Zehn Jahre Molekulares Tumorboard: von der Genomsequenzierung zur personalisierten Krebstherapie
    Benedikt Färber, Jan Morf, Jan Vorwerk, Johanna Schwandt, Paul Lennart Tiemann, Niklas Gebauer, Cyrus Khandanpour, Nikolas C. C. von Bubnoff · 2025 · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie
  10. SUMOylation substrate encoding genes as prognostic biomarkers in pancreatic ductal adenocarcinoma with functional assessment of SAF-B2
    Xiangjun Wang, Chuanxin Yang, Yangming Liu, Jian Wang · 2025 · Frontiers in Pharmacology
  11. Integration of single cell and bulk transcriptomes identifies T cell stress subtypes in LUAD
    Shengping Min, Linfeng Pan, Xinyu Zhang, Huili Chen, Lixuan Qiu, Xinyu Wang, Yiluo Xie, Kai Zhang, Qıang Zhang, Chaoqun Lian et al. · 2025 · Discover Oncology
  12. Advancing Prostate Cancer Treatment: Innovations and Challenges in Immunotherapy
    Gargi Singhal, Pankaj Garg, Atish Ranjan Mohanty, Sudarsan Vishnu Kollimuttathuillam, Deric L. Wheeler, Bamidele A. Adesunloye, Sharad S. Singhal · 2025 · Cancer treatment and research
  13. Clinical significance of ANXA9 expression in colorectal cancer and its impact on immune evasion and drug resistance
    Min Cheol Hong, Qian Dong, Huiming Zhu, Xu Huang · 2025 · Discover Oncology
  14. Exploring relationships between tumor mutation burden with immunity and prognosis in lung adenocarcinoma based on weighted gene co‐expression network analysis
    Haiyong Wu, Jinzhuo Ren, Zhipeng Gong, Yan Zhang, Hua Zhang, Weikang Chen, Chenyang Zhao, Tao Fang · 2025 · Precision Medical Sciences
  15. Deep Learning Radiomic Signature Predicts the Overall Survival of Patients with Lung Adenocarcinoma by Reflecting the Tumor Heterogeneity and Microenvironment
    Chunlei Dai, Bo Huang, Zhe Yu, Jingwei Xu, Jian Li, Jian Yang · 2025 · Academic Radiology
  16. Systematic pan-cancer analysis reveals the prognostic and immunological roles of ectonucleoside triphosphate diphosphohydrolase 6
    Gang Wang, Tao Liu, Jiaxing Zhang, Yi‐Rong Li, Wei-Jing Zhu, Jinglan Wang, Wei-Wei Dong, Yuyu Zhang, Yumin Li, Lu-Xi Yang et al. · 2025 · World Journal of Clinical Oncology
  17. The Role of Immunotherapy in Treating Lung Cancer: Current Status and Future Perspective
    Carlton Bijesh Ray, Vinesan Vijayarasa, Maariyah Vankad, Mohamed Ashur Sherif, Amer Harky · 2021 · Future Drug Discovery
  18. An exploration of LAF‐bTMB as a predictor for the efficacy of immunotherapy combined with chemotherapy in non—small cell lung cancer
    Shuyang Zhang, Lu Yang, Yaning Yang, Ying Xin, Yan Wang · 2022 · Thoracic Cancer
  19. Systematic integration of machine learning algorithms to develop immune escape-related signatures to improve clinical outcomes in lung adenocarcinoma patients
    Ting I. Wang, Lin Huang, Jie Zhou, Li Lü · 2023 · Frontiers in Immunology
  20. Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma
    Mengxi Wu, Zhenyu Wu, Jun Yan, Jie Zeng, Jun Kuang, Chenghua Zhong, Xiaojia Zhu, Yijun Mo, Quanwei Guo, Dongfang Li et al. · 2023 · Frontiers in Oncology
  21. Pan-Cancer Indicators of Long-Term Survival Benefits After Immune Checkpoint Inhibitor Therapy
    Jie Zhao, Yiting Dong, Hua Bai, Jianchun Duan, Rui Wan, Jiachen Xu, Kailun Fei, Jie Wang, Zhijie Wang · 2022 · SSRN Electronic Journal
  22. ATG101 as a Novel Prognostic Biomarker Related to Immunotherapy in Pan-cancer
    Zijian Zhang, Jinggang Mo, Chong Jin, Hao Jiang, Zhongtao Liu, Heng Zou, Xiong Li, Chuang Teng, Yu Wen, Kunpeng Wang · 2021 · Research Square
  23. Prognosis Prediction Based on Cuproptosis-Related lncRNAs and Immune Responses in Patients with LUAD
    Qianhui Zhou, Yi Liu, Hongtao Duan, Lingli Quan, Yan Gao, Lin Wang, Jiaxiang Liu, Zain Abbas, Jean Bosco Nzeyimana, Shafqat Qamer et al. · 2022 · Preprints.org
  24. Multi-omics analysis reveals the impact of intratumor microbes on lung adenocarcinoma prognosis and ICB treatment
    Yi Zhang, Mingshuang Li, Weilin Li, Yufeng Chen, Dan Cheng · 2023 · Research Square
  25. From Pixels to Insights: Unveiling Spatial Immune Associations of Immunotherapy Response in Non-Small Cell Lung Cancer using Multiplexed Tissue Imaging
    Arutha Kulasinghe, James H. Monkman, Afshin Moradi, Joseph Yunis, Geoffrey T. Ivison, Aaron T. Mayer, Rahul Ladwa, Kenneth John O'Byrne · 2023 · Research Square
  26. The Role of CDCA3 in Disulfidptosis: Implications for Breast Cancer Cell Viability and Treatment
    Min‐Bin Chen, An-Ran Wang, Xiaoren Zhu, xaioren zhu, Yuanyuan Liu, YuJiao Wu, Mengen Xue · 2024 · Research Square
  27. Can a dysfunctional T-cell gene signature predict nonresponse to PD-1 blockade in non-small cell lung cancer?
    Hirokazu Taniguchi, Kazuto Ashizawa, Hiroshi Mukae · 2024 · Translational Lung Cancer Research
  28. Predicting Tumor Mutational Burden from UHF-Dielectrophoresis Crossover Frequency
    Héloïse Daverat, Nina Blasco, Sandrine Robert, Arnaud Pothier, Amandine M.F. Rovini, Marie Boutaud, Charlotte Jemfer, Claire Dalmay A, Fabrice Lalloué, Karine Durand et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Toward a better pan-tumor predictive signature for unleashing precision immuno-oncology
    Jason Robert Brown, Guru Sonpavde · 2025 · Journal for ImmunoTherapy of Cancer
  30. Expression signature, prognosis value, and immune characteristics of MUC1 identified by pan-cancer analysis
    Zijian Zhang, Yun-peng Huang, Zhong-Tao Liu, Kai Liu, Yongxiang Wang, Yang Yang, Li Xiong, Heng Zou, Yu Ching Wen · 2021 · Research Square
  31. Genetic and tumor microenvironment differences between cell cycle progression pathway altered/non-altered patients with lung adenocarcinoma
    Guangyao Shan, Guoshu Bi, Yunyi Bian, Valeria Besskaya, Dejun Zeng, Huan Zhang, Guangyu Yao, Yi Zhang, Hong Bo Fan, Cheng Zhan · 2021 · Research Square
  32. An immune-associated gene prognostic index risk model for stomach adenocarcinoma
    Weijie Xue, Bingzi Dong, Yixiu Wang, Yuwei Xie, Qingkai Xue, Zezhao Gong, Chengzhan Zhu, Zhaojian Niu · 2021 · Research Square
  33. Integrated analysis of the underlying immunomodulator and survival signature of STON1 gene in kidney renal clear cell carcinoma
    Axiu Zheng, Jianrong Bai, Yanping Ha, Bingshu Wang, Yuan Zou, Caixia Wu, Jingci Xing, Shaojiang Zheng, Zhihua Shen, Botao Luo et al. · 2021 · Research Square
  34. Experience of the nivolumab use in patients with metastatic renal cell carcinoma provided under the expanded access program in Russia. Subgroup analysis of the correlation between expression markers and the effectiveness of nivolumab therapy
    N. V. Karpova, M.  V. Ivanov, В А Милейко, А. А. Rumyantsev, Татьяна Александровна Титова, G. A. Arakelyan, A.  P. Oganesyan, Alexandra V. Kanygina, Elena Ivanovna Sharova, Rustem Airatovich Gafanov et al. · 2022 · Malignant tumours
  35. A Robust Immune-Related Risk Model Predicts Clinical Outcomes and Characterizes Immunophenotypes in Triple-Negative Breast Cancer Patients
    Xun‐Xi Lu, Zongchao Gou, Luoting Yu, Hong Bu · 2021 · SSRN Electronic Journal
  36. Molekulare Diagnostik in der Pathologie: etablierte Marker und Innovationen
    Kirsten Reuter‐Jessen, Philipp Ströbel · 2022 · Der Onkologe
  37. Universality of distribution of tumor mutation burden - a biomarker for the tumor evolution and disease risk
    Xin Li, Sumit Sinha, Dave Thirumalai · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Integrated analysis of LRP2 mutation to immunotherapy efficacy in pan-cancer cohort
    Chunbo Li, Yan Ding, Xuyin Zhang, Keqin Hua · 2022 · Research Square
  39. Prognostic and immunological role of MRC1: A pan-cancer analysis
    Heyuan Huang, Jingwei Zhang, Changhao Huang, Xiang Ding · 2022 · Research Square
  40. Comprehensive Pan-Cancer Analysis Reveals PTPN2 as an Immune Checkpoint and Prognostic Biomarker
    Xiaolong Tang, Xue Sui, Yongshuo Liu · 2022 · SSRN Electronic Journal
  41. Integrated analysis of LRP2 mutation to immunotherapy efficacy in pan-cancer cohort
    Chunbo Li, Yan Ding, Xuyin Zhang, Keqin Hua · 2022 · Research Square
  42. APOBEC3B Improves Response to PD-1 Blockade Through DSBs–ATR–CHK1 Pathway
    Hong Yang, Shiyu Chen, Yueyun Ma, Rong Wang, Yanxia Wang, Qin Zeng, Wei Guo, Bin Xie, Xiaomei Zhou, Tongxin Liu et al. · 2022 · Research Square
  43. Identification of the immune infiltration landscape and development of the prognostic signature on cuproptosis-related genes in colorectal cancer
    Yihan Kang, Siqiao Zhao, Chang Xu, Jihe Huang, Jin Wang, Yutong Chen · 2022 · Research Square
  44. Cuproptosis-related IncRNAs predict prognosis and immune reponse of lung adenocarcinoma IncRNAs predict lung adenocarcinoma
    Fangwei Wang, Hongsheng Lin, Qisheng Su, Chaoqian Li · 2022 · Research Square
  45. CD8+ T Cell/Cancer-Associated Fibroblasts Ratio Stratifies Prognostic and Predictive Responses to Immunotherapy Across Multiple Cancer Types
    Xinlong Zheng, Kan Jiang, Weijin Xiao, Dongqiang Zeng, Dongqiang Zeng, Jing Bai, Xiaohui Chen, Pan-Song Li, Longfeng Zhang, Longfeng Zhang et al. · 2022 · SSRN Electronic Journal
  46. Development and Validation of a Novel Prognostic Model for Glioma Based on Immune-Related Genes
    Jinpeng Hu, Hao Ran Li, Jinkun Xu, Lian Chen, Chunjiao Yang, Guoqing Zhang, Shengliang Zong, Junhua Chen, Zhitao Jing · 2022 · Research Square
  47. Molekularpathologische Diagnostik des Harnblasenkarzinoms – prädiktive und prognostische Marker
    Jan H. Rüschoff, Holger Moch · 2022 · Die Onkologie
  48. A novel N7 ‐methylguanosine‐related long noncoding RNAs signature for predicting prognosis and immune microenvironment in gastric cancer patients
    Peisen Guo, Panpan Wang, Limin Liu, Peixi Wang, Zhi Qu, Zengli Yu, Nan Liu · 2022 · Precision Medical Sciences
  49. Tumor cell density dependent IL-8 secretion induces the fluctuation of Tregs/CD8+ T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpoint
    Mengchao Yan, Jia Yao, Yan Lin, Jun Yan, Ye Xie, Yongqiang Zhou, Jiayun Wei, Xun Li · 2022 · Research Square
  50. Association of the CD4+ /CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatologic toxicities in patients with advanced gastric and esophageal cancer
    Shuangwei Xu, Lixia Wu, Qiuwei Zhu, Yinghe Zhong, Yaoyao Wang, Jingmiao Wang, Jinbi Yan, Lina Zhu, Junjie Hang · 2022 · Research Square
  51. Biomarkers and Outcomes in Diverse Cancers: Meta-Analysis of Early Phase Immuno-Oncology Trials
    Elena Fountzilas, Henry Hiep Vo, Peter J. Mueller, Razelle Kurzrock, Apostolia Maria Tsimberidou · 2022 · Research Square
  52. MMP9 in Pan-Cancer and Computational Study to Screen MMP9 Inhibitors
    Bo Wu, Xinyu Wang, Chunzheng Chen, Qifan Yang, Pengcheng Zhou, Shiyuan Lu, Liangxin Lin, Yanwei Liu, Ming Li, Dong Zhu · 2023 · Research Square
  53. LINC00261 expression reduces mutation accumulation while conferring resistance to cisplatin and altering the tumor-immune microenvironment in lung adenocarcinoma
    Jonathan Castillo, Tianchun Xue, Samantha Joseph, Mayela Norwood, Daniel J. Mullen, Stephanie Berrellez, Sophia James, Alan L. Epstein, Troy A. McEachron, Crystal N. Marconett · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  54. A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
    Haiyan Li, Hao Lan, Menglong Li, Xuemei Pu, Yanzhi Guo · 2023 · Frontiers in Pharmacology
  55. Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
    Yanlin Tang, Changzheng Zhang, Chujin Ye, Kaiwen Tian, Jiayi Zeng, Shouyu Cheng, Weinan Zeng, Bowen Yang, Yanjun Liu, Yuming Yu · 2023 · Heliyon
  56. Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers
    Matteo Bellone, Anna Mondino · 2023 · European Urology Oncology
  57. Exploration of cuproptosis-Related Long Non-Coding RNA Signature to predict the clinical outcome and Immune Microenvironment in Cervical Cancer
    Bihui Wang, Yuejie Zhu, Yulian Zhang, Zhenyu Ru, Jianbing Ding, Zhifang Chen · 2023 · Research Square
  58. Certification of novel lncRNA based on analysis of ceRNA network in digestive system pan-cancer and characteristics of tumor immune microenvironment
    Zikang He, Shuang Liang, Guoli Li, Xueyan Wang, Ping Shen, Huan Wang, Rongjun Cui · 2023 · Research Square
  59. Glycolysis rate-limiting enzyme PFKP: A pan-cancer predictor for prognostic significant, immunological correlation, and drug sensitivity prediction
    Jian Ming Peng, Pingping Li, Yuan Li, Jichuan Quan, Yanwei Yao, Junfang Duan, Xuemei Liu, Hao Li, Dajiang Yuan, Xiaoru Wang · 2023 · Research Square
  60. Ex vivo quantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chip
    Irina Veith, Arianna Mencattini, Martin Nurmik, Isabelle Damei, Christine Lansche, Solenn Brosseau, Giacomo Gropplero, Stéphanie Corgnac, Joanna Filippi, Nicolas Poté et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Construction of an M1 macrophage-related lncRNA signature for predicting the tumor immune microenvironment
    Qi Wu, Yiming Liu, Qingsong Hu, Huihui Wu · 2023 · JUSTC
  62. High expression of cuproptosis-related gene DLD in relation to good prognosis and immune cells infiltration in colon cancer
    Fan Ling, Ning Lü, Lingmin Zhang, Jie Zhang, Jie Li, Zhaoxiang Yu, Manli Cui, Mingxin Zhang · 2023 · Research Square
  63. Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy response
    Xiaoyan Su, Junzhe Liu, Zewei Tu, Qiankun Ji, Jingying Li, Fanrong Liu · 2023 · Research Square
  64. Identification of Triple-Negative Breast Cancer Subtypes Based on Ferroptosis- Related Gene Signature for Targeted Treatment Prioritization
    Yongzhen Chen, Xiaoying Huang, Haining Wang, Yanan Zheng, Zhongping Su, Tao Ling, Yujie Xu, Qiang You, Jie Ji, Ting Zhao · 2023 · Research Square
  65. Identifification of amino acid metabolic signature to predict prognosis and guide clinical therapy in patients with Hepatocellular carcinoma
    Dalin Chen, Huizhong Jiang, Bing Yang, Bin Guo, Dan Li, Guangze Ye, Yang Zhu, Dongxin Tang, FengXi Long · 2023
  66. Construction of a Hypoxia-related lncRNA Prognostic Model for Bladder Urothelial Carcinoma Based on TCGA Database
    Junliang Chen, Chongyu Zhao · 2023 · World Journal of Clinical Medicine
  67. CAR T cells and dendritic cells: vaccinomics perspectives
    Dito Anurogo · 2023 · International Physical Medicine & Rehabilitation Journal
  68. Angiogenesis-related lncRNAs index: A predictor for CESC prognosis, immunotherapy efficacy, and chemosensitivity
    Siqi Gou, Xueyuan Huang, Jiayu Xu, Alexander Tobias Teichmann, Jing Zhang, Rui Wang, Guanhu Yang, Hao Chi, Qin Wang · 2023 · Research Square
  69. Precision clinical genomics and single subject studies of multi-omics data
    Hirotaka Miyashita, Shumei Kato, Jason Keith Sicklick · 2023 · Elsevier eBooks
  70. Comprehensive Pan‐Cancer Analysis Reveals the Potential Biological, Immunological, and Prognostic Value of NKG2A
    Yao Rong, Yongfeng Wang, Mingzheng Tang, Guiqian Zhang, Yuan Yuan, Fengyuan Dong, Zhihang Wu, Guorong Ma, Songhua Liu, Xiashuang Zhao et al. · 2023 · Analytical Cellular Pathology
  71. A novel disulfidptosis-related lncRNA signature predicts prognosis and therapeutic response in low-grade glioma
    Yu-qiao Song, X X Wang · 2023 · Research Square
  72. Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy
    Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Giulia Schiavoni, Irene Terrenato, Alessandro Di Federico, Joao V. Alessi et al. · 2023 · medRxiv
  73. NeoHeadHunter: an algorithm for the detection, ranking and probabilistic classification of neoepitope candidates
    Xiaofei Zhao · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Immune-related gene prognostic index (IRGPI) for lung adenocarcinoma predicts patient prognosis and immunotherapy response.
    Zheng Gang Zhu, Feng Wei, Xiao-Yan Tan, Pin-Chao Gu, Wei Song, Haitao Ma · 2023 · PubMed Central
  75. Construct a prognostic model based on fatty acid metabolism/ferroptosis-related genes and reveal the immune heterogeneity and somatic mutation specificity of rectal adenocarcinoma in different groups
    Jie Wang, Hongyun Chen, Yanli Qu, Meng Xu, Genyan Guo, Qi Ju, Yang Yu, Xin Jian Jiang, Xu Guo, Guohua Zhao · 2023 · Research Square
  76. SKP1: A novel target for prognosis predicting and precise treatment in human cancers
    Wei-Ying He · 2023 · Research Square
  77. A Perspective Review of Cancer Therapy (Part II): Adoptive Cell Transfer, Metabolic Therapy, and Artificial Intelligence
    Alberto Pajuelo · 2023 · Science Insights
  78. EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of Treatment
    Yiting Zhang, Lin-jing Xu, Ling Li · 2024 · Genetic Testing and Molecular Biomarkers
  79. Pan-cancer analysis of the role of SPC25 in human cancer
    Qi Wang, wensong Wu, Awuti Aisha, Jiayan Xin, Fan Chang, Jianghui Zhang, Shuai Tang, Zheng Lv, Fangmin Chen · 2024 · Research Square
  80. A pan-cancer analysis has uncovered CCDC58, a mitochondrial gene associated with epilepsy, as a potential prognostic and immunotherapeutic biomarker for various cancer types, including gliomas
    Zhipeng You, Cong Huang, Jiran Li, Yang Liu, Wei Fan, Zhijie Fan, Xingan Liu, Jiahang Sun · 2024 · Research Square
  81. Prognostic significance and immunologic features of the paired-box (PAXs) family: a pan-cancer multi- omics analysis
    Xiaoliang Zhou, Yixin Qi, Qiangqiang Xia, Han Yang, Chong Shen, Chenyang Han, Zongliang Zhang, Linhui Wang, Ming Tan, Ke Wang et al. · 2024 · Research Square
  82. ImmuneScore as a novel RNA-based prognostic signature superior to PD-L1 in advanced non-squamous NSCLC patients receiving chemotherapy combined with immune checkpoint inhibitor therapy
    Zhi‐Huan Lin, Jianhua Zhan, Li Zhang · 2024 · Journal of Cancer Metastasis and Treatment
  83. Mechanisms and potential applications of COPS6 in pan-cancer therapy
    Tong Tong Wu, Miao-Rong Ji, Lianxiang Luo · 2024 · World Journal of Clinical Oncology
  84. Additional file 1 of A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden
    Fei Wu, Yuanyuan Du, Xiujuan Hou, Wei Cheng · 2022 · Figshare
  85. Additional file 2 of Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer
    Jianlu Song, Rexiati Ruze, Yuan Chen, Ruiyuan Xu, Xinpeng Yin, Chengcheng Wang, Qiang Xu, Yupei Zhao · 2022 · Figshare
  86. Additional file 1 of Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis
    Jiacheng Wu, Ni Li, Linwen Zhu, Zhen, Dawei, Mengqi Li, Hang Chen, Mengmeng Ye, Yiqin Wei, Guofeng Shao · 2022 · Figshare
  87. Additional file 2 of A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden
    Fei Wu, Yuanyuan Du, Xiujuan Hou, Wei Cheng · 2022 · Figshare
  88. Additional file 1 of Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma
    Cai‐Feng Lin, Zhi‐Wen Chen, Feng‐Ping Kang, Jianfei Hu, Long Huang, Cheng‐Yu Liao, Jianlin Lai, Yi Huang, Zuwei Wang, Yifeng Tian et al. · 2023 · Figshare
  89. Additional file 3 of A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden
    Fei Wu, Yuanyuan Du, Xiujuan Hou, Wei Cheng · 2022 · Figshare
  90. Identification of a novel favorable STAD subtype based on multi-omics data Integration
    Hui Dai, Jing Ren, Chun Wang, Haotian Zhang, Xinhui Lv, Jiyuan Yang, Xudong Wang · 2024 · Research Square
  91. Integrated analysis of single-cell and bulk RNA sequencing to construct a CD8+ T cell-related immune gene signature in pancreatic cancer
    Yuzhi Liu, Fei Xu, Anyi Jiang, Jie Ding, Chungao Li, Ming Quan · 2024 · Journal of Pancreatology
  92. DHCR7 is a potential pan cancer biomarker for prognosis and immunotherapy
    Xianghua Wu, Qinyuan Gong, Xiaoliang Xu, Li Wang, Xuzhao Zhang, Teng Yu, Gesheng Zhu, Weiwei Zheng, Dan Lin, Zhaoxing Wu · 2024 · Research Square
  93. Angiogenesis-related lncRNAs index: A predictor for CESC prognosis, immunotherapy efficacy, and chemosensitivity
    Xueyuan Huang, Guangming Yi, Jiayu Xu, Siqi Gou, Haiqing Chen, Xiaoyan Chen, Xiaomin Quan, Linjia Xie, Alexander Tobias Teichmann, Guanhu Yang et al. · 2024 · Journal of Cancer
  94. Discovery of a T cell proliferation-associated regulator signature correlates with prognosis risk and immunotherapy response in bladder cancer
    Ting Yan, Wei Zhou, Chun Li · 2024 · International Urology and Nephrology
  95. Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity
    Gergő Mihály Balogh · 2023
  96. Exploring the potential value of SRC genes in pan cancer based on bioinformatics methods
    Liyin Huang, Tao Si, Yanwen Lu, Lei Yi, Yuxin Zhao, Mingmin Zhang · 2024 · Research Square
  97. Exploring the multifaceted role of key lncRNA in glioma: From genetic expression to clinical implications and immunotherapy potential
    Sen Zhao, Meimei Liu, Hua Zhou · 2024 · Heliyon
  98. Exploring and optimizing therapeutic strategies for borderline ovarian tumors and low-grade serous ovarian cancer
    Koen De Decker · 2024
  99. A multidimensional Pan-cancer analysis of CDKN1A identifies CDKN1A as an Immunological and Prognostic Biomarker
    Wenyang Zhang, Qinglong Ma, Wenrun Li, Honghui Zhao, Linghui Zhong, Yinan Xiao, Yaru Ren, Kaixin Yang, Yonghong Li, Lei Shi · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Bioinformatical and experimental validation on EFNA5 biomarker for pancreatic cancer
    Ze Hua, Rongshuang Zhao, Wenbo Guan, Siya Liu, Jurui Ge, Yiran Zhang, Suliman Khan, Zhenjie Pan, Jian Wang · 2024 · Arabian Journal of Chemistry